29 Oct 2013, BioSpectrum Bureau , BioSpectrum
Singapore: AusBiotech and Korea Biotechnology Industry Organization (KoreaBIO) are signing a memorandum of understanding (MoU) recognizing the key role of biotechnology in economic and social development.
The strategic partynership would be signed beetween AusBiotech and KoreaBIO, which are the industry associations representing the biotechnology industries of Australia and Korea respectively.
Dr Eun-Hee Bae, president of the Korea Biotechnology Industry Organization, and Dr Anna Lavelle, AusBiotech's CEO will sign the MoU to promote collaboration and cooperation in the area of biotechnology. Representative from the Strategic Planning Department of KoreaBIO, Ms You-me Choi, and members of AusBiotech Board, including chairman, Dr Deborah Rathjen, will be present at the MoU signing ceremony, which will be held during the AusBiotech 2013 national conference in Brisbane.
The objectives of the MoU are for both parties to promote cooperation in biotechnology in areas of mutual interest those relevant to economic and social development; promote the exchange of views in supporting the formulation and application of biotechnology policy by government; and facilitate interaction between officials, scientists and technologists of Korea and Australia.
The MoU encourages and supports increased interaction between Korea and Australian biotechnology companies through access to visitor office facilities in Seoul and Melbourne to support members of KoreaBIO and AusBiotech when in Korea and Australia.